EUVIMEDEUVIMED entdecken
Crossref

Impact of Adjuvant Radiotherapy on Recurrence Outcomes in pT2N0 Oral Squamous Cell Carcinoma: A Propensity Score–Matched Survival Analysis

Hemant Nemade iD, Abhinav Thaduri iD, Jonathan T Gondi iD, Sravan Kumar Chava iD, Anil Kumar Akula iD, Abhilash Konkimalla iD, Daphne Fonseca iD, Sahithi Shilpa Arya, Deleep Kumar Gudipudi, Ashwini Gopal iD, L M Chandra Sekara Rao S iD

Head & Neck · 09.07.2026

DOI: 10.1002/hed.70391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 09.07.2026. Verfasst von Hemant Nemade und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The benefit of adjuvant radiotherapy in pT2N0 oral squamous cell carcinoma (OSCC) remains uncertain. We evaluated its impact on disease‐free survival (DFS) using propensity score matching.

Methods

Patients with pT2N0 OSCC treated between 2015 and 2023 were identified from a prospectively maintained database. One‐to‐one nearest‐neighbor propensity score matching was performed using age, tumor size, depth of invasion, perineural invasion, lymphovascular invasion, margin distance, tumor subsite, histological grade, and bilateral neck dissection status. Three‐year DFS was analyzed using Kaplan–Meier methods and Cox regression.

Results

Among 400 eligible patients, 226 underwent surgery alone, and 174 received adjuvant radiotherapy. Propensity score matching generated 107 matched pairs. Three‐year DFS was 78.3% for surgery alone and 82.1% for surgery plus radiotherapy ( p = 0.41). Adjuvant radiotherapy was not associated with improved DFS (HR 0.81, 95% CI 0.48–1.30; p = 0.43).

Conclusions

In this propensity score–matched cohort, adjuvant radiotherapy was not associated with improved 3‐year DFS in pT2N0 OSCC.

Autor:innen und Institutionen

  • Department of Head and Neck Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
  • Department of Pathology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
  • Department of Radiation Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.

ORCID-Profile: Hemant Nemade, Abhinav Thaduri, Jonathan T Gondi, Sravan Kumar Chava, Anil Kumar Akula, Abhilash Konkimalla, Daphne Fonseca, Ashwini Gopal, L M Chandra Sekara Rao S

Zitieren

APA

Nemade, H., Thaduri, A., Gondi, J. T., Chava, S. K., Akula, A. K., Konkimalla, A., Fonseca, D., Arya, S. S., Gudipudi, D. K., Gopal, A., & Rao S, L. M. C. S. (2026). Impact of Adjuvant Radiotherapy on Recurrence Outcomes in pT2N0 Oral Squamous Cell Carcinoma: A Propensity Score–Matched Survival Analysis. Head & Neck. https://doi.org/10.1002/hed.70391

Vancouver

Nemade H, Thaduri A, Gondi JT, Chava SK, Akula AK, Konkimalla A, et al. Impact of Adjuvant Radiotherapy on Recurrence Outcomes in pT2N0 Oral Squamous Cell Carcinoma: A Propensity Score–Matched Survival Analysis. Head & Neck. 2026. doi:10.1002/hed.70391

BibTeX
@article{Nemade2026,
  author = {Nemade, Hemant and Thaduri, Abhinav and Gondi, Jonathan T and Chava, Sravan Kumar and Akula, Anil Kumar and Konkimalla, Abhilash and Fonseca, Daphne and Arya, Sahithi Shilpa and Gudipudi, Deleep Kumar and Gopal, Ashwini and Rao S, L M Chandra Sekara},
  title = {Impact of Adjuvant Radiotherapy on Recurrence Outcomes in pT2N0 Oral Squamous Cell Carcinoma: A Propensity Score–Matched Survival Analysis},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70391}
}
Kostenlos starten →